vs

Side-by-side financial comparison of Clearwater Paper Corp (CLW) and Vir Biotechnology, Inc. (VIR). Click either name above to swap in a different company.

Clearwater Paper Corp is the larger business by last-quarter revenue ($360.3K vs $240.0K, roughly 1.5× Vir Biotechnology, Inc.). Clearwater Paper Corp runs the higher net margin — -3.6% vs -67975.4%, a 67971.9% gap on every dollar of revenue. On growth, Clearwater Paper Corp posted the faster year-over-year revenue change (-4.7% vs -89.9%). Over the past eight quarters, Vir Biotechnology, Inc.'s revenue compounded faster (-88.0% CAGR vs -96.8%).

Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.

Vir Biotechnology, Inc. is a clinical-stage immunology company focused on developing innovative therapies and vaccines to address serious infectious diseases including COVID-19, hepatitis B, HIV, and influenza. It operates primarily in the global biopharmaceutical market, collaborating with leading industry partners to advance its pipeline of targeted immune-based solutions for patient populations worldwide.

CLW vs VIR — Head-to-Head

Bigger by revenue
CLW
CLW
1.5× larger
CLW
$360.3K
$240.0K
VIR
Growing faster (revenue YoY)
CLW
CLW
+85.2% gap
CLW
-4.7%
-89.9%
VIR
Higher net margin
CLW
CLW
67971.9% more per $
CLW
-3.6%
-67975.4%
VIR
Faster 2-yr revenue CAGR
VIR
VIR
Annualised
VIR
-88.0%
-96.8%
CLW

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CLW
CLW
VIR
VIR
Revenue
$360.3K
$240.0K
Net Profit
$-12.8K
$-163.1M
Gross Margin
-0.2%
Operating Margin
-72267.9%
Net Margin
-3.6%
-67975.4%
Revenue YoY
-4.7%
-89.9%
Net Profit YoY
-103.2%
23.7%
EPS (diluted)
$-1.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLW
CLW
VIR
VIR
Q1 26
$360.3K
Q4 25
$386.4M
Q3 25
$399.0M
$240.0K
Q2 25
$391.8M
$1.2M
Q1 25
$378.2M
$3.0M
Q4 24
$387.1M
$12.4M
Q3 24
$393.3M
$2.4M
Q2 24
$344.4M
$3.1M
Net Profit
CLW
CLW
VIR
VIR
Q1 26
$-12.8K
Q4 25
$38.3M
Q3 25
$-53.3M
$-163.1M
Q2 25
$2.7M
$-111.0M
Q1 25
$-6.3M
$-121.0M
Q4 24
$199.1M
Q3 24
$5.8M
$-213.7M
Q2 24
$-25.8M
$-138.4M
Gross Margin
CLW
CLW
VIR
VIR
Q1 26
-0.2%
Q4 25
4.5%
Q3 25
4.7%
Q2 25
11.0%
99.1%
Q1 25
9.7%
Q4 24
3.8%
Q3 24
7.7%
97.9%
Q2 24
-0.6%
98.3%
Operating Margin
CLW
CLW
VIR
VIR
Q1 26
Q4 25
1.9%
Q3 25
-13.9%
-72267.9%
Q2 25
2.5%
-9754.3%
Q1 25
-1.1%
-4602.5%
Q4 24
-4.0%
Q3 24
-0.3%
-9718.7%
Q2 24
-13.6%
-5158.7%
Net Margin
CLW
CLW
VIR
VIR
Q1 26
-3.6%
Q4 25
9.9%
Q3 25
-13.4%
-67975.4%
Q2 25
0.7%
-9139.9%
Q1 25
-1.7%
-3989.6%
Q4 24
51.4%
Q3 24
1.5%
-8979.7%
Q2 24
-7.5%
-4500.1%
EPS (diluted)
CLW
CLW
VIR
VIR
Q1 26
Q4 25
$2.36
Q3 25
$-3.30
$-1.17
Q2 25
$0.17
$-0.80
Q1 25
$-0.38
$-0.88
Q4 24
$11.87
Q3 24
$0.35
$-1.56
Q2 24
$-1.55
$-1.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLW
CLW
VIR
VIR
Cash + ST InvestmentsLiquidity on hand
$36.5M
$497.8M
Total DebtLower is stronger
$361.1M
Stockholders' EquityBook value
$813.8M
$796.1M
Total Assets
$1.6B
$1.0B
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLW
CLW
VIR
VIR
Q1 26
$36.5M
Q4 25
$30.7M
Q3 25
$34.4M
$497.8M
Q2 25
$46.7M
$598.7M
Q1 25
$44.0M
$790.9M
Q4 24
$79.6M
$901.0M
Q3 24
$35.5M
$909.0M
Q2 24
$39.6M
$1.1B
Total Debt
CLW
CLW
VIR
VIR
Q1 26
$361.1M
Q4 25
$346.8M
Q3 25
$337.0M
Q2 25
$330.1M
Q1 25
Q4 24
$283.4M
Q3 24
$1.2B
Q2 24
$1.1B
Stockholders' Equity
CLW
CLW
VIR
VIR
Q1 26
$813.8M
Q4 25
$825.3M
Q3 25
$783.0M
$796.1M
Q2 25
$836.8M
$947.5M
Q1 25
$836.6M
$1.0B
Q4 24
$854.6M
$1.2B
Q3 24
$664.6M
$1.2B
Q2 24
$658.6M
$1.4B
Total Assets
CLW
CLW
VIR
VIR
Q1 26
$1.6B
Q4 25
$1.6B
Q3 25
$1.6B
$1.0B
Q2 25
$1.6B
$1.2B
Q1 25
$1.6B
$1.3B
Q4 24
$1.7B
$1.4B
Q3 24
$2.5B
$1.5B
Q2 24
$2.5B
$1.7B
Debt / Equity
CLW
CLW
VIR
VIR
Q1 26
0.44×
Q4 25
0.42×
Q3 25
0.43×
Q2 25
0.39×
Q1 25
Q4 24
0.33×
Q3 24
1.73×
Q2 24
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLW
CLW
VIR
VIR
Operating Cash FlowLast quarter
$-167.6M
Free Cash FlowOCF − Capex
$-167.9M
FCF MarginFCF / Revenue
-69952.9%
Capex IntensityCapex / Revenue
132.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-824.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLW
CLW
VIR
VIR
Q1 26
Q4 25
$5.0M
Q3 25
$34.0M
$-167.6M
Q2 25
$-28.2M
$-120.2M
Q1 25
$1.5M
$-78.1M
Q4 24
$-35.1M
$-446.4M
Q3 24
$16.2M
$-171.5M
Q2 24
$21.1M
$-77.8M
Free Cash Flow
CLW
CLW
VIR
VIR
Q1 26
Q4 25
$-9.9M
Q3 25
$15.7M
$-167.9M
Q2 25
$-51.1M
$-122.8M
Q1 25
$-31.2M
$-79.7M
Q4 24
$-68.1M
$-453.7M
Q3 24
$-30.8M
$-174.2M
Q2 24
$3.0M
$-78.5M
FCF Margin
CLW
CLW
VIR
VIR
Q1 26
Q4 25
-2.6%
Q3 25
3.9%
-69952.9%
Q2 25
-13.0%
-10111.8%
Q1 25
-8.2%
-2630.1%
Q4 24
-17.6%
-3666.2%
Q3 24
-7.8%
-7321.3%
Q2 24
0.9%
-2553.3%
Capex Intensity
CLW
CLW
VIR
VIR
Q1 26
Q4 25
3.9%
Q3 25
4.6%
132.1%
Q2 25
5.8%
209.1%
Q1 25
8.6%
53.7%
Q4 24
8.5%
59.0%
Q3 24
12.0%
116.3%
Q2 24
5.3%
21.7%
Cash Conversion
CLW
CLW
VIR
VIR
Q1 26
Q4 25
0.13×
Q3 25
Q2 25
-10.44×
Q1 25
Q4 24
-0.18×
Q3 24
2.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons